Exploring RAS mutation incidence and temporal heterogeneity in metastatic colorectal cancer patients - a single-institution experience utilising circulating tumour DNA.

George ZarkavelisAnna Lea AmylidiNanteznta TorounidouMelina YerolatsiteAthanasia KeravasiliVarvara KeramisanouDavide Mauri

Published in: Contemporary oncology (Poznan, Poland) (2024)

Our findings contribute to our understanding of the evolving mutational landscape and the potential clinical implications of ctDNA ana- lysis in the era of personalised cancer medicine.

Keyphrases

metastatic colorectal cancer
end stage renal disease
circulating tumor
ejection fraction
newly diagnosed
single cell
chronic kidney disease
prognostic factors
papillary thyroid
peritoneal dialysis
risk factors
patient reported outcomes
squamous cell
human health
nucleic acid